High expression of FGFR4 has been described already for breast cancer (Lehtola et al, 1992; Jaakkola et al, 1993), pancreatic cancer (Leung et al, 1994) and renal cell carcinoma (Takahashi et al, 1999). Here, FGFR4 is linked to pancreatic neoplasm.